Bolt Biotherapeutics, Inc. - Common Stock (BOLT)
0.4010
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 6:19 AM EDT

BOLT stock results show that Bolt Biotherapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 13, 2024

Explore key stocks with analyst uncertainty to avoid amid contrasting global market highs and risky downgrades.
Via InvestorPlace · May 24, 2024

Via Benzinga · May 15, 2024

Via Benzinga · March 30, 2023

During Friday's morning session, 234 stocks hit new 52-week lows.
Interesting Facts About Today's 52-Week Lows:
The largest company in terms of market cap...
Via Benzinga · April 8, 2022

Via Benzinga · May 15, 2024

Via Benzinga · May 15, 2024

Via Benzinga · May 15, 2024

Via Benzinga · May 15, 2024

We are covering the biggest pre-market stock movers for Wednesday with all of the latest happenings worth watching this morning!
Via InvestorPlace · May 15, 2024

BOLT stock results show that Bolt Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 14, 2024

Via Benzinga · May 14, 2024

Via Benzinga · April 3, 2024

BOLT stock results show that Bolt Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 21, 2024

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies is considering strategic alternatives for non-core operations including, not limited to possible sale/other disposition of assets.
Via Benzinga · October 2, 2023

Via Benzinga · May 12, 2023

Via Benzinga · March 30, 2023

Via Benzinga · August 11, 2022

SVB Leerink cut the price target on Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) from $8 to $4. SVB Leerink analyst Daina Graybosch downgraded the stock from Outperform to Market Perform. Bolt Biotherapeutics shares fell 3.2% to $2.44 in pre-market trading.
Via Benzinga · August 11, 2022

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The company's market cap stands at $16.7 million.
Via Benzinga · July 20, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Via Benzinga · July 8, 2022

Bolt Biotherapeutics (NASDAQ:BOLT) brought in sales totaling $508.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 16.08%, resulting in a loss of $27.16 million.
Via Benzinga · March 31, 2022

Gainers
Soleno Therapeutics (NASDAQ:SLNO) shares rose 15.7% to $0.37 during Monday's pre-market session. The market value of their outstanding shares is at $29.5...
Via Benzinga · February 28, 2022

On Wednesday, 160 companies hit new 52-week lows.
Areas of Significance In Today's 52-Week Lows:
Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...
Via Benzinga · April 20, 2022